Cargando…

N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma

Increasing evidence suggests that N6-methyladenosine (m6A) and long non-coding RNAs (lncRNAs) play important roles in cancer progression and immunotherapeutic efficacy in clear-cell renal cell carcinoma (ccRCC). In this study, we conducted a comprehensive ccRCC RNA-seq analysis using The Cancer Geno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Tianming, Wang, Xiaonan, Wang, Jiawen, Liu, Xiaodong, Lai, Shicong, Zhang, Wei, Meng, Lingfeng, Tian, Zijian, Zhang, Yaoguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554127/ https://www.ncbi.nlm.nih.gov/pubmed/34721523 http://dx.doi.org/10.3389/fgene.2021.726369

Ejemplares similares

An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer
por: Ma, Tianming, et al.
Publicado: (2021)

m6A Methylation Patterns and Tumor Microenvironment Infiltration Characterization in Clear-Cell Renal Cell Carcinoma
por: Ma, Tianming, et al.
Publicado: (2022)

Nomograms to predict individual prognosis of patients with primary signet ring cell carcinoma of the urinary bladder
por: Ma, Tianming, et al.
Publicado: (2021)

Young age increases the risk of lymph node positivity but improves prognosis in patients with bladder cancer treated via cystectomy: a population-based study
por: Ma, Tianming, et al.
Publicado: (2021)

Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining
por: Meng, Lingfeng, et al.
Publicado: (2021)

Prognostic Characteristics and Immune Effects of N(6)-Methyladenosine and 5-Methylcytosine-Related Regulatory Factors in Clear Cell Renal Cell Carcinoma
por: Li, Lei, et al.
Publicado: (2022)

N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma
por: Wang, Guowei, et al.
Publicado: (2022)

Novel amino acid metabolism‐related gene signature to predict prognosis in clear cell renal cell carcinoma
por: Cheng, Xiaofeng, et al.
Publicado: (2022)

An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma
por: Yu, Qingxin, et al.
Publicado: (2022)

An Immune-Related Gene Signature Can Predict Clinical Outcomes and Immunotherapeutic Response in Oral Squamous Cell Carcinoma
por: Zhang, Liyuan, et al.
Publicado: (2022)

Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Ren, Xueting, et al.
Publicado: (2021)

An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma
por: Li, Jiaying, et al.
Publicado: (2022)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma
por: Chen, Zhuo, et al.
Publicado: (2022)

The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022)

Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis
por: Zhang, Jingcheng, et al.
Publicado: (2023)

Gene Signature Associated With Bromodomain Genes Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Lu, Junwan, et al.
Publicado: (2021)

A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Peng, Linjie, et al.
Publicado: (2022)

A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma
por: Zhou, Tao, et al.
Publicado: (2022)

Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer
por: Yu, Xinshuang, et al.
Publicado: (2021)

Genomics and Prognosis Analysis of N(6)-Methyladenosine Regulators in Lung Adenocarcinoma
por: Ma, Yanpin, et al.
Publicado: (2021)

Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
por: Zhao, Jianhui, et al.
Publicado: (2021)

Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma
por: Yao, Zhi-Yong, et al.
Publicado: (2021)

The Clinical Significance of DNA Damage Repair Signatures in Clear Cell Renal Cell Carcinoma
por: Guo, Ergang, et al.
Publicado: (2021)

A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients
por: Shen, Cheng, et al.
Publicado: (2022)

Identification of Novel Glycolysis-Related Gene Signatures Associated With Prognosis of Patients With Clear Cell Renal Cell Carcinoma Based on TCGA
por: Wu, Chengjiang, et al.
Publicado: (2020)

Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
por: Na, Zhijing, et al.
Publicado: (2021)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Distribution Patterns of DNA N6-Methyladenosine Modification in Non-coding RNA Genes
por: Li, Yu, et al.
Publicado: (2020)

Identification of a Metastasis-Associated Gene Signature of Clear Cell Renal Cell Carcinoma
por: Gao, Suhua, et al.
Publicado: (2021)

Expression of AOX1 Predicts Prognosis of Clear Cell Renal Cell Carcinoma
por: Xiong, Luyang, et al.
Publicado: (2021)

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022)

An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
por: Li, Gen, et al.
Publicado: (2022)

Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma
por: Xu, Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u2f5lc947braluu5qfbkkponvc